Xiaoli Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Hedgehog Signaling Pathway Studies
- Nicotinic Acetylcholine Receptors Study
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
-
- Nicotinic Acetylcholine Receptors Study 17
- RNA modifications and cancer 13
- Epigenetics and DNA Methylation 9
- Receptor Mechanisms and Signaling 8
- Cancer-related gene regulation 7
- Oncology 23
- Co-authors
- Hao Hu (7 shared papers)Yanfei Jia (53 shared papers)Ying Sun (2 shared papers)Haiji Sun (23 shared papers)Yang Liu (2 shared papers)Airong Qian (10 shared papers)Peihong Su (7 shared papers)Ye Tian (7 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)Cancer Letters (4 papers)Oncotarget (3 papers)Biochemical and Biophysical Research Communications (3 papers)Carcinogenesis (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoli Ma
136 papers receiving 3.1k citations
Xiaoli Ma's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 410
- Molecular Biology 1.5k
- Oncology 425
- Biomaterials 186
- Molecular Medicine 66
Countries citing papers authored by Xiaoli Ma
This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).
Fields of papers citing papers by Xiaoli Ma
This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Influence of Cell Cycle Regulation on Chemotherapy Hit paper breakdown → | 2021 | 201 |
| 2 | 2018 | 185 | |
| 3 | 2005 | 160 | |
| 4 | 2005 | 135 | |
| 5 | 2020 | 88 | |
| 6 | 2020 | 81 | |
| 7 | 2016 | 79 | |
| 8 | 2021 | 70 | |
| 9 | 2017 | 63 | |
| 10 | 2014 | 58 | |
| 11 | 2012 | 56 | |
| 12 | 2021 | 46 | |
| 13 | 2017 | 43 | |
| 14 | 2015 | 43 | |
| 15 | 2008 | 43 | |
| 16 | 2021 | 42 | |
| 17 | 2018 | 42 | |
| 18 | 2008 | 41 | |
| 19 | 2016 | 40 | |
| 20 | 2013 | 40 |
About Xiaoli Ma
Xiaoli Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 142 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (17 papers), RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (10 papers), Cancer, Stress, Anesthesia, and Immune Response (10 papers), Epigenetics and DNA Methylation (9 papers), Receptor Mechanisms and Signaling (8 papers), Cancer-related gene regulation (7 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Cancer Research (410 citations), Molecular Biology (1.5k citations), Oncology (425 citations), Biomaterials (186 citations) and Molecular Medicine (66 citations). Xiaoli Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hao Hu, Yanfei Jia, Ying Sun, Haiji Sun, Yang Liu, Airong Qian, Peihong Su, Ye Tian, Dongjie Xiao and Yunshan Wang. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Letters, Oncotarget, Biochemical and Biophysical Research Communications and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.